Landec to Present at the 28th Annual ROTH Conference on March 14, 2016

MENLO PARK, Calif., March 03, 2016 (GLOBE NEWSWIRE) -- Landec Corporation LNDC, a leading developer and marketer of innovative and proprietary products for healthy living applications in the food and biomedical markets, has been invited to present at the 28^th Annual ROTH Capital Partners Conference being held March 13-16, 2016 at The Ritz-Carlton in Dana Point, California.

Landec CEO Molly Hemmeter is scheduled to present on Monday, March 14 at 3:30 p.m. Pacific time. She will discuss Landec's businesses, market leadership, strategies and progress.

For additional information or to schedule a one-on-one meeting with Landec management, please contact your ROTH representative.

About Landec Corporation

Landec Corporation is a company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio, has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology with the capabilities of large scale processing and national distribution. Lifecore Biomedical, a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP (current good manufacturing practices) validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements.  For more information about the company, visit Landec's website at www.landec.com.